Jessica M. Stempel

Faculty @OHSUKnight l @YaleHemOnc Fellow l @ASH_hematology Trainee Council 2022-2024 l MD-UCV 🇻🇪 - views are my own

[Maryam Lustberg MD, MPH, FASCO @maryam_lustberg]

Drs Melissa Taylor and Devora Isseroff @YaleHemOnc @YaleCancer #sabcs24 #bcsm

[Yale Cancer Center @YaleCancer]

Dr. Nikolai Podoltsev presents @eaonc E1910 Ph III trial of the addition of Blinatumomab to consolidation therapy for older, newly diagnosed patients with BCR::ABL1 negative B-Lineage Acute Lymphoblastic Leukemia #ALL #ASH24 with Selina Loger, MD @PennCancer & @MRLitzow https://t.co/up0lzs680l

[Yale Cancer Center @YaleCancer]

Celebrating Dr. Jennifer Afranie-Sakyi, @YaleHemOnc, and her presentation of implementation rates of the @ASH_hematology cerebrovascular guideline screening for silent cerebral infarct and cognition in #sicklecelldisease #SCD at #ASH24! @cececalhounMD @YaleHematology @SmilowCancer
https://t.co/kSm0WDJ0az

[Yale Hematology Oncology Fellows @YaleHemOnc]

So proud of you Nicole!

[tariqkewan @tariqkewan]

Had an amazing time at #ASH2024 meeting friends, attending great talks and finally getting the great news of passing my Hematology ABIM while enjoying this great view of SD.

[Amer Zeidan عامر زيدان @Dr_AmerZeidan]

Dr Luca Lanino @YaleCancer @HumanitasMilano presenting an excellent project that developed a molecular classification & a new, independently validated, risk stratification tool that outperformed all the other available for #CMML in collaboration with @genomed4all @ic_MDS

[Yale Cancer Center @YaleCancer]

.@KunalPotnis reveals that at the current pricing, eltrombopag plus traditional immunosuppressive therapy is unlikely to be a cost-effective treatment for adults with severe aplastic anemia in the US. #ASH24 @GeorgeGoshuaMD @YaleHematology @SmilowCancer https://t.co/ztySpPoq7K

[Jessica M. Stempel @JMStempel]

@Hamza_HassanMD @Dr_AmerZeidan @AACR @ASH_hematology PDG-12 🔥🔥🔥

[Jessica M. Stempel @JMStempel]

@XimeJordan @ASH_hematology @LatinasInMed Thank you @XimeJordan @PamChMD !! Love meeting and connecting with colleagues at #ASH24 @ASH_hematology !! @LatinasInMed

[Jessica M. Stempel @JMStempel]

Excited to share our work! Thank you @Dr_AmerZeidan @Dr_RoryShallis for your mentorship and support!

[Amer Zeidan عامر زيدان @Dr_AmerZeidan]

Dr @JMStempel fantastically presented our investigator-initiated randomized phase 2 trial of aza-ven +/- Pembro in older #AMLsm #ASH24 which was unfortunately -ve but showed importance of using ELN2024 for risk stratification & feasibility of central MRD in primary endpoint #IMG

[Yale Cancer Center @YaleCancer]

An overview of treatment patterns & outcomes of CAR-T & Bispecific T-Cell Engager BiTE therapies in Relapsed/Refractory #MultipleMyeloma from @S@SmilowCancer @YaleCancer, presented by Poy Theprungsirikul, MD @YaleHemOnc #ASH24 @NataliaNeparid1NataliaNeparid1 @YaleHematology https://t.co/5EfIMIycsR

[Jessica M. Stempel @JMStempel]

Incredible work by @Alhajahjeh_Abd !!

[Abdulrahman Alhajahjeh, MD @Alhajahjeh_Abd]

Thank you @Dr_AmerZeidan for all the great support you give me I will make sure to be at the intended level.

[Terri Parker @Terri_ParkerMD]

Happy to present on behalf of my coauthors including you!

[Kelsey Martin, MD @drkelseymartin]

Beautiful run! @JMStempel @NataliaNeparid1 @YaleHematology @YaleHemOnc #ASH24 #ASH5K

[Yale Cancer Center @YaleCancer]

.@JMStempel & Dr. Nikolai Podoltsev share research demonstrating that Calcineurin Inhibitor + Eltrombopag is effective in reducing transfusion requirements for patients w acquired #AplasticAnemia. #ASH24 @Sm@SmilowCancer @YaleHemOnc @YaleHematology @OncoAlert
https://t.co/WSXkh9KYTr

[Jessica M. Stempel @JMStempel]

Enjoying a chilly morning run before #ASH24 !!

[Ximena Jordan Bruno @XimeJordan]

It was a pleasure to participate in this rapid mentoring sessions! Always happy to contribute even with encouraging words in the journey of the next generation of hematologists ❤️
@KellyMezaMD @MaryCushmanMD
@GomezDLeonMD @JMStempel
#mentoring #ASHEducation #ASH24 @ClaudSVillaCeli

[LaraKRotter @LaraKimR]

@Dr_AmerZeidan @YaleMed @Alhajahjeh_Abd Wondering why so many clinical trials end prematurely? Our latest research digs into this critical issue. This work would not have been possible without such an excellent team @Alhajahjeh_Abd @JMStempel @Dr_AmerZeidan @MaxStahlMD @BewersdorfJan...@TradIMYale @YaleMedPSTP

[Valentina Restrepo, MD @vale_restrepo1]

🚨Calling all Hematology & Oncology doctors! Please take this 5-minute survey on grit and resilience ➡ https://t.co/8HIj6iTX4z

[Yale Hematology Oncology Fellows @YaleHemOnc]

It might take us a second to coordinate getting a group picture, but it's because we just like each other. And we certainly love our first year fellows class! It was a joy learning about each of you at the Heme-Onc Fellows Welcome Party. You already make our family richer. 💙